Varda has closed a $251M Series D to scale its business of making pharmaceuticals in orbit.
Space seems to offer benefits for pharma manufacturing, as the lack of gravity allows ingredients to crystallize together in ways that would be impossible on Earth, creating more effective medicines. #varda
